These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 37208883

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R, Al Rumhi T, Al Abri AM.
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [Abstract] [Full Text] [Related]

  • 24. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [Abstract] [Full Text] [Related]

  • 25. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 26. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Antoon JW, Goldman JL, Lee B, Schwartz A.
    Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761
    [Abstract] [Full Text] [Related]

  • 27. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR, Blaylock RC, Morris SE, Jung JY.
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [Abstract] [Full Text] [Related]

  • 28. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A, Devrim İ, Çağlar İ, Bayram N, Kundak S, Apa H, Altan EV.
    Turk J Pediatr; 2019 Aug; 61(4):538-543. PubMed ID: 31990471
    [Abstract] [Full Text] [Related]

  • 29. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK, Martin AM, Agarwal N, D'Souza P, Das S, Kumar R, Pande S, Das NK, Kumaresan M, Kumar P, Garg A, Singh S.
    Indian J Dermatol Venereol Leprol; 2016 Aug; 82(6):603-625. PubMed ID: 27716721
    [Abstract] [Full Text] [Related]

  • 30. Bronchiolitis obliterans associated with toxic epidermal necrolysis induced by infection: A case report and literature review.
    Liu J, Yan H, Yang C, Li Y.
    Front Pediatr; 2023 Aug; 11():1116166. PubMed ID: 36937984
    [Abstract] [Full Text] [Related]

  • 31. Warfarin-induced toxic epidermal necrolysis after mitral valve replacement.
    Kuroda T, Yokoyama Y, Yamada M, Yuhara S, Hasegawa H, Yokote J.
    Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):601-603. PubMed ID: 32787441
    [Abstract] [Full Text] [Related]

  • 32. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC.
    J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
    [Abstract] [Full Text] [Related]

  • 33. Dermatologic emergencies.
    Usatine RP, Sandy N.
    Am Fam Physician; 2010 Oct 01; 82(7):773-80. PubMed ID: 20879700
    [Abstract] [Full Text] [Related]

  • 34. Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.
    Stern RS, Chan HL.
    J Am Acad Dermatol; 1989 Aug 01; 21(2 Pt 1):317-22. PubMed ID: 2671067
    [Abstract] [Full Text] [Related]

  • 35. Ofloxacin: a probable cause of toxic epidermal necrolysis.
    Melde SL.
    Ann Pharmacother; 2001 Nov 01; 35(11):1388-90. PubMed ID: 11724089
    [Abstract] [Full Text] [Related]

  • 36. Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.
    Ramien ML, Mansour D, Shear NH.
    Paediatr Drugs; 2022 Jul 01; 24(4):307-319. PubMed ID: 35676614
    [Abstract] [Full Text] [Related]

  • 37. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ, Heck JN.
    J Oncol Pharm Pract; 2015 Oct 01; 21(5):388-92. PubMed ID: 25005569
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Terbinafine-induced Steven-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap.
    Banik B, Bhar D, Sil A.
    Postgrad Med J; 2021 Oct 01; 97(1152):630-631. PubMed ID: 32665378
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.